Polymer-based drug-delivery strategies can sometimes be hampered by the poor stability of polymer–drug conjugates and their ineffectual drug-release profiles. Here, the authors fabricate a cyclodextrin-based polymer–drug nano-assembly and demonstrate effective in vivotumour reduction activity.
- Ran Namgung
- Yeong Mi Lee
- Won Jong Kim